FEBRUARY 21, 2022 Director's Column PNNL Coronavirus Research Unlocks Clues for Fighting COVID-19 Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19. ( Read More )
JANUARY 25, 2022 Research Highlight Pharmacokinetic Model Accurately Predicts Dose Implications of a Chemical Carcinogen Across Species Simulations reveal advantages of using new model vs. allometric scaling for risk assessment. ( Read More )
JANUARY 11, 2022 Staff Accomplishment Rethinking the Defense Against Unknown Biothreats PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense. ( Read More )
NOVEMBER 2, 2021 News Release Cellular Quality-Control System Identified as a Culprit in Coronavirus Infection A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections. ( Read More )
OCTOBER 20, 2021 Staff Accomplishment Lancaster Publishes Book Chapter on Cyberbiosecurity Mary Lancaster, epidemiologist and data scientist, co-authored a chapter on cyberbiosecurity for the NATO Science for Peace and Security book series. ( Read More )
OCTOBER 11, 2021 Research Highlight Combining Metabolic Activity, Rates, and Exposure to Refine Risk of Environmental Hazards Exposure to polycyclic aromatic hydrocarbons found at Superfund Sites induces enzymes in dose- and time-dependent patterns in mice. ( Read More )
AUGUST 12, 2021 Feature Zeroing in on Zoonotic Diseases A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health. ( Read More )
FEBRUARY 24, 2021 Feature PNNL Participates in COVID-19 Community Dialogues and Support Efforts As the COVID-19 pandemic continues, PNNL is offering support to its neighbors in the Mid-Columbia region and across Washington State. ( Read More )
